Triptolide can effectively alleviate myocardial hypertrophy by inhibiting left ventricular remodeling, elevating the myocardial expression of Foxp3, and correcting the imbalance of expression of α-MHC and β-MHC. This evidence concerns the gene FOXP3 and cardiac hypertrophy.